| Product Code: ETC9959352 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Antipsychotic Drugs Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Antipsychotic Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Antipsychotic Drugs Market - Industry Life Cycle |
3.4 United States (US) Antipsychotic Drugs Market - Porter's Five Forces |
3.5 United States (US) Antipsychotic Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 United States (US) Antipsychotic Drugs Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 United States (US) Antipsychotic Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of mental health disorders in the US |
4.2.2 Technological advancements leading to the development of more effective antipsychotic drugs |
4.2.3 Growing awareness and acceptance of mental health treatment in society |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval and marketing of antipsychotic drugs |
4.3.2 High cost associated with research and development of new antipsychotic medications |
4.3.3 Side effects and safety concerns associated with some antipsychotic drugs |
5 United States (US) Antipsychotic Drugs Market Trends |
6 United States (US) Antipsychotic Drugs Market, By Types |
6.1 United States (US) Antipsychotic Drugs Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Antipsychotic Drugs Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 United States (US) Antipsychotic Drugs Market Revenues & Volume, By First Generation, 2021- 2031F |
6.1.4 United States (US) Antipsychotic Drugs Market Revenues & Volume, By Second Generation, 2021- 2031F |
6.1.5 United States (US) Antipsychotic Drugs Market Revenues & Volume, By Third Generation, 2021- 2031F |
6.2 United States (US) Antipsychotic Drugs Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Antipsychotic Drugs Market Revenues & Volume, By Schizophrenia, 2021- 2031F |
6.2.3 United States (US) Antipsychotic Drugs Market Revenues & Volume, By Bipolar disorder, 2021- 2031F |
6.2.4 United States (US) Antipsychotic Drugs Market Revenues & Volume, By Unipolar depression, 2021- 2031F |
6.2.5 United States (US) Antipsychotic Drugs Market Revenues & Volume, By Dementia, 2021- 2031F |
6.2.6 United States (US) Antipsychotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Antipsychotic Drugs Market Import-Export Trade Statistics |
7.1 United States (US) Antipsychotic Drugs Market Export to Major Countries |
7.2 United States (US) Antipsychotic Drugs Market Imports from Major Countries |
8 United States (US) Antipsychotic Drugs Market Key Performance Indicators |
8.1 Patient adherence rates to antipsychotic drug regimens |
8.2 Rate of adoption of new antipsychotic medications in the US market |
8.3 Number of clinical trials for antipsychotic drugs conducted in the US |
8.4 Prescription rates for antipsychotic drugs compared to other mental health treatments |
8.5 Number of healthcare providers specializing in mental health prescribing antipsychotic drugs |
9 United States (US) Antipsychotic Drugs Market - Opportunity Assessment |
9.1 United States (US) Antipsychotic Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 United States (US) Antipsychotic Drugs Market Opportunity Assessment, By Application, 2021 & 2031F |
10 United States (US) Antipsychotic Drugs Market - Competitive Landscape |
10.1 United States (US) Antipsychotic Drugs Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Antipsychotic Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here